National Medical Care Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

National Medical Care wird ein jährliches Gewinn- und Umsatzwachstum von 11.4% bzw. 12% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 17.5% betragen.

Wichtige Informationen

9.1%

Wachstumsrate der Gewinne

9.0%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	14.6%
Wachstumsrate der Einnahmen	12.3%
Zukünftige Eigenkapitalrendite	18.3%
Analystenabdeckung	Good
Zuletzt aktualisiert	24 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Apr 05

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

Mar 14

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Mar 13

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Dec 27

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Dec 05

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Aug 07

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

May 29

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

May 08

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Dec 19

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Oct 19

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Aug 15

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

May 13

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 03

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

Feb 09

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 27

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Jan 14

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Dec 25

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Nov 24

Gewinn- und Umsatzwachstumsprognosen

SASE:4005 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SAR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,594	367	302	417	4
12/31/2025	1,467	342	206	389	6
12/31/2024	1,310	291	132	308	6
3/31/2024	1,119	266	212	423	N/A
12/31/2023	1,082	241	412	467	N/A
9/30/2023	1,034	233	825	690	N/A
6/30/2023	997	202	670	531	N/A
3/31/2023	968	196	349	386	N/A
12/31/2022	918	170	185	217	N/A
9/30/2022	882	151	-162	52	N/A
6/30/2022	857	142	-126	86	N/A
3/31/2022	843	131	8	45	N/A
12/31/2021	845	136	56	94	N/A
9/30/2021	844	122	58	94	N/A
6/30/2021	845	105	15	49	N/A
3/31/2021	828	100	17	40	N/A
12/31/2020	809	97	88	107	N/A
9/30/2020	780	95	187	198	N/A
6/30/2020	740	95	216	225	N/A
3/31/2020	724	83	155	162	N/A
12/31/2019	708	80	152	162	N/A
9/30/2019	705	65	236	246	N/A
6/30/2019	707	60	245	259	N/A
3/31/2019	737	67	188	206	N/A
12/31/2018	764	62	299	318	N/A
9/30/2018	810	81	199	231	N/A
6/30/2018	842	96	194	236	N/A
3/31/2018	859	95	217	279	N/A
12/31/2017	855	85	N/A	113	N/A
9/30/2017	817	-8	N/A	-9	N/A
6/30/2017	806	-7	N/A	70	N/A
3/31/2017	849	33	N/A	72	N/A
12/31/2016	901	50	N/A	103	N/A
9/30/2016	931	155	N/A	87	N/A
6/30/2016	945	153	N/A	63	N/A
3/31/2016	913	136	N/A	77	N/A
12/31/2015	879	131	N/A	51	N/A
9/30/2015	853	106	N/A	127	N/A
6/30/2015	820	102	N/A	80	N/A
3/31/2015	772	91	N/A	38	N/A
12/31/2014	734	95	N/A	71	N/A
9/30/2014	703	106	N/A	32	N/A
6/30/2014	660	103	N/A	15	N/A
3/31/2014	623	94	N/A	75	N/A
12/31/2013	586	92	N/A	79	N/A
9/30/2013	560	97	N/A	138	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 4005Das prognostizierte Gewinnwachstum (13.1% pro Jahr) liegt unter der Sparquote (14.3%).

Ertrag vs. Markt: 4005Die Erträge des Unternehmens (13.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt SA (6.8% pro Jahr).

Hohe Wachstumserträge: 4005Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 4005Die Einnahmen des Unternehmens (12.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt SA (-0.3% pro Jahr).

Hohe Wachstumseinnahmen: 4005Die Einnahmen des Unternehmens (12% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 4005Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (18.2 %).

National Medical Care Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 9.3% to ر.س196

Price target increased by 9.0% to ر.س165

Price target increased by 8.5% to ر.س151

Consensus EPS estimates increase by 10%

Price target increased by 7.6% to ر.س144

Price target increased by 13% to ر.س103

Recent updates

Now 21% overvalued

National Medical Care Company Approves Cash Dividend for the Financial Period December 31, 2023, Payable on 12 June 2024

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Now 21% overvalued after recent price rise

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Now 24% overvalued after recent price rise

Price target increased by 9.3% to ر.س196

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Price target increased by 9.0% to ر.س165

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Price target increased by 8.5% to ر.س151

Consensus EPS estimates increase by 10%

Price target increased by 7.6% to ر.س144

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

National Medical Care Company (SASE:4005) signed share purchase agreement to acquire Chronic Care Specialized Medical Hospital Company from Saudi Medical Care Group for SAR 193.21 million.

Second quarter 2023 earnings released: EPS: ر.س1.07 (vs ر.س0.94 in 2Q 2022)

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Price target increased by 13% to ر.س103

National Medical Care Company (SASE:4005) completed the acquisition of Jiwar Medical Services Company from SmartMed.

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

Investor sentiment improves as stock rises 18%

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Consensus EPS estimates increase by 11%

Investor sentiment improves as stock rises 20%

Price target increased by 14% to ر.س86.80

Full year 2022 earnings: EPS exceeds analyst expectations

National Medical Care Company (SASE:4005) signed a non-binding memorandum of understanding to acquire Jiwar Medical Services Company from SmartMed for SR 65 million.

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Less than half of directors are independent

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Now 20% undervalued

National Medical Care Company Announces Executive Appointments

Consensus EPS estimates increase by 16%

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Second quarter 2022 earnings released: EPS: ر.س0.94 (vs ر.س0.69 in 2Q 2021)

National Medical Care Company, Annual General Meeting, Sep 06, 2022

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

Less than half of directors are independent

Now 20% undervalued

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Full year 2021 earnings: EPS and revenues miss analyst expectations

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Third quarter 2021 earnings released: EPS ر.س0.74 (vs ر.س0.36 in 3Q 2020)

Second quarter 2021 earnings released: EPS ر.س0.69 (vs ر.س0.57 in 2Q 2020)

Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

First quarter 2021 earnings released: EPS ر.س0.80 (vs ر.س0.74 in 1Q 2020)

Consensus forecasts updated

Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Full year 2020 earnings released: EPS ر.س2.17 (vs ر.س1.79 in FY 2019)

Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

New 90-day low: ر.س49.70

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

National Medical Care Company Obtains the Initial Approval to Renew its Contract with the General Organization

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

New 90-day low: ر.س50.60

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Third quarter 2020 earnings released: EPS ر.س0.36